Catalysis by retroviral integrase (IN). (A), Shows the steps known to occur in vivo. (B), Shows the steps that can be measured separately in vitro using short oligodeoxyribonucleotide duplexes (oligos) that represent a viral DNA end (heavy lines) and a target DNA (light lines). The last four nucleotides in the 3′-ends of HIV-1 DNA are shown. Open circles indicate 3′-OH ends; filled circles, 5′-PO₄ ends.

Binding of HIV-1 IN to a 6-FAM-labeled, recessed viral DNA oligo. (A), Illustration of the reaction. (B), Anisotropy measurements. Diamonds (dashed lines) show results with 6-His-tagged IN; solid lines are results with untagged IN. Solid symbols show binding in the presence of MgCl₂; open symbols, in the presence of MnCl₂. (C), Structure of 6-carbofluorescein (6-FAM). Conjugation occurs through the terminal phosphate.

Processing by 6-His-tagged or untagged HIV-1 IN in the presence of MgCl₂. (A), Illustration of the reaction. (B), Diamonds (dashed lines) show product released with 6-His-tagged IN, and squares (solid line) with untagged IN.

Fluorescent joining assay of 6-His-tagged or untagged HIV-1 IN in the presence of MgCl₂ or MnCl₂. (A), Illustrates the single end joining assay in which the product is bound to streptavidin-coated beads via the biotin-conjugated target oligo. The bound FAM-labeled viral strand is released upon denaturation by addition of NaOH. The amount of released, FAM-labeled viral strand is then quantified. (B), Joining activity as a function of time in the presence of MgCl₂. (C), Joining activity as a function of time in the presence of MnCl₂. Note the 10-fold increase in scale compared with (B). In this assay 400 RFU ≃1% joining of viral oligo. Diamonds (dashed lines) represent data points with 6-His-tagged IN; squares (solid lines) with untagged IN.